30114-002

Company

Adicet Bio, Inc.

Filed

February 12, 2021

Accession Number

0000919574-21-000929

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →